Reader response: Alemtuzumab CARE-MS II 5-year follow-up: Efficacy and safety findings
- PMID: 30224507
- DOI: 10.1212/01.wnl.0000544324.09014.0e
Reader response: Alemtuzumab CARE-MS II 5-year follow-up: Efficacy and safety findings
Comment in
-
Author response: Alemtuzumab CARE-MS II 5-year follow-up: Efficacy and safety findings.Neurology. 2018 Sep 18;91(12):581-582. doi: 10.1212/WNL.0000000000006203. Neurology. 2018. PMID: 30224508 No abstract available.
Comment on
-
Alemtuzumab CARE-MS II 5-year follow-up: Efficacy and safety findings.Neurology. 2017 Sep 12;89(11):1117-1126. doi: 10.1212/WNL.0000000000004354. Epub 2017 Aug 23. Neurology. 2017. PMID: 28835403 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources